Evonik Industries (FRA:EVK) has been assigned a €31.00 ($36.05) price target by analysts at Sanford C. Bernstein in a research note issued to investors on Thursday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Sanford C. Bernstein’s target price indicates a potential upside of 26.63% from the stock’s current price.
Other analysts have also issued reports about the company. Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a “buy” rating in a research report on Tuesday, April 2nd. Warburg Research set a €35.75 ($41.57) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday, May 7th. UBS Group set a €23.00 ($26.74) price target on shares of Evonik Industries and gave the stock a “sell” rating in a research note on Tuesday, May 7th. Berenberg Bank set a €31.00 ($36.05) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Wednesday, May 8th. Finally, Morgan Stanley set a €34.00 ($39.53) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Friday, March 22nd. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company’s stock. Evonik Industries presently has an average rating of “Hold” and a consensus price target of €30.90 ($35.93).
Evonik Industries stock traded down €0.21 ($0.24) during midday trading on Thursday, reaching €24.48 ($28.47). The stock had a trading volume of 616,410 shares. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.